Actuate Therapeutics
$1.5000
4
+$0.02+1.35% 11:15 Today
Statistics
Day High
1.505
Day Low
1.48
52W High
8.8
52W Low
0.9
Volume
5,244
Avg. Volume
-
Mkt Cap
35.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.33
-0.28
-0.22
-0.17
Expected EPS
-0.17
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-22.23MNet Income
Analyst Ratings
10.50Average Price Target
The highest estimate is 15.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ACTU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
Show more...
CEO
Daniel Schmitt
Employees
12
Country
United States
ISIN
US0050831009
Listings
0 Comments
Share your thoughts
FAQ
What is Actuate Therapeutics stock price today?▼
The current price of ACTU is $1.50 USD — it has increased by +1.35% in the past 24 hours. Watch Actuate Therapeutics stock price performance more closely on the chart.
What is Actuate Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Actuate Therapeutics stocks are traded under the ticker ACTU.
Is Actuate Therapeutics stock price growing?▼
ACTU stock has fallen by -3.9% compared to the previous week, the month change is a +33.94% rise, over the last year Actuate Therapeutics has showed a -81.36% decrease.
What is Actuate Therapeutics market cap?▼
Today Actuate Therapeutics has the market capitalization of 35.54M
When is the next Actuate Therapeutics earnings date?▼
Actuate Therapeutics is going to release the next earnings report on December 02, 2026.
What were Actuate Therapeutics earnings last quarter?▼
ACTU earnings for the last quarter are -0.2 USD per share, whereas the estimation was -0.2 USD resulting in a +1.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Actuate Therapeutics revenue for the last year?▼
Actuate Therapeutics revenue for the last year amounts to 0 USD.
What is Actuate Therapeutics net income for the last year?▼
ACTU net income for the last year is -22.23M USD.
How many employees does Actuate Therapeutics have?▼
As of September 08, 2026, the company has 12 employees.
In which sector is Actuate Therapeutics located?▼
Actuate Therapeutics operates in the Health & Wellness sector.
When did Actuate Therapeutics complete a stock split?▼
The last stock split for Actuate Therapeutics was on August 15, 2000 with a ratio of 2:1.
Where is Actuate Therapeutics headquartered?▼
Actuate Therapeutics is headquartered in FORT WORTH, United States.